US FDA to hold workshop on nanomaterial-containing devices
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration plans to hold a public workshop on 23 September to gather information on the manufacturing, characterisation and biocompatibility evaluation of medical devices and diagnostics that contain or use nanomaterials and nanostructures.